The current landscape for cannabis companies is confusing due to the divergence between federal and state law. Under federal law, particularly under the Controlled Substances Act (CSA),[1] cannabis is a Schedule 1 controlled substance, and cannabis activities from cultivation to sale are illegal. Yet more than 30 states now have laws making those activities permissible for medical use, recreational use or both. This divergence presents tremendous challenges for the cannabis business.